Moderna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'
Go back to Moderna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 63.02 -0.63 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.65 | 52 Week High | $0.52 | |||
| Open | $62.89 | 52 Week Low | $0.08 | |||
| Day High | $63.78 | P/E | N/A | |||
| Day Low | $60.82 | EPS | $-3.80 | |||
| Volume | 2,262,563 | |||||
